Baker Hughes clears HSR for Chart deal; close expected mid‑2026
Baker Hughes Company announced a key regulatory milestone for its planned acquisition of Chart Industries.
Rhea-AI Filing Summary
Baker Hughes Company announced a key regulatory milestone for its planned acquisition of Chart Industries. The waiting period under the Hart-Scott-Rodino Act expired at 11:59 p.m. Eastern Time on November 6, 2025, satisfying one of the conditions required to complete the merger.
The companies continue to expect the transaction to close in mid-year 2026, subject to customary closing conditions and receipt of other applicable regulatory approvals. Chart would become an indirect wholly owned subsidiary of Baker Hughes upon completion. The filing also reiterates standard forward-looking statement cautions about integration, financing, regulatory approvals, and timing risks.
Positive
- None.
Negative
- None.
Insights
HSR waiting period expired; closing still subject to other approvals.
The expiration of the HSR waiting period removes a U.S. antitrust gating item for the Baker Hughes–Chart Industries merger. This step indicates no further action by U.S. antitrust authorities within the initial review window, allowing the deal to proceed to remaining conditions.
Completion still depends on “customary conditions” and “other applicable regulatory approvals,” which can include non-U.S. reviews or sector-specific clearances. The companies continue to signal an expected closing in mid-year 2026, but that timing remains contingent on approvals and closing mechanics.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Baker Hughes (BKR) announce regarding the Chart Industries deal?
When do Baker Hughes and Chart Industries expect the merger to close?
What happens to Chart Industries after the deal closes?
Are there additional approvals required for the Baker Hughes–Chart merger?
What risks did Baker Hughes highlight about the transaction?
What securities of Baker Hughes are listed on Nasdaq?
AI-generated analysis. How Rhea-AI works. Not financial advice.